Although synergy between systemic ɑ4-1BB and ɑCTLA-4 has been reported in the MC38 model, it was not previously reported to be efficacious in a B16 melanoma model, again highlighting the importance of the antitumor antibody and local retention through collagen anchoring in our therapy68. Here, TNFRSF9 is linked to melanoma.